Page last updated: 2024-08-26

lopinavir and Parasitemia

lopinavir has been researched along with Parasitemia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Akelo, V; Angira, F; Chen, H; Coombs, R; Hogg, E; Kosgei, J; Kumwenda, J; McKhann, A; Murphy, SC; Schooley, R; Shaffer, D; Ssali, F; Stewart, VA; Tonui, R	1
Bachovchin, W; Baldwin, MR; Chishti, AH; Hanada, T; Hegde, S; Levin, AE; Okure, C; Schiemer, J; Schwake, C; Vannier, E	1
Achan, J; Arinaitwe, E; Charlebois, E; Clark, TD; Dorsey, G; Havlir, D; Ikilezi, G; Kakuru, A; Kamya, MR; Muhindo, MK; Mwangwa, F; Rosenthal, PJ; Ruel, T; Tappero, JW	1

Trials

2 trial(s) available for lopinavir and Parasitemia

Article	Year
Brief Report: No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297). Journal of acquired immune deficiency syndromes (1999), 2022, 02-01, Volume: 89, Issue:2 Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Parasitemia; Plasmodium falciparum; Reverse Transcriptase Inhibitors; Ritonavir	2022
Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Aug-01, Volume: 59, Issue:3 Topics: Antimalarials; Artemisinins; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Lopinavir; Malaria; Male; Nevirapine; Parasitemia; Quinolines; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Outcome; Uganda	2014

Article

Year

Brief Report: No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297).

Journal of acquired immune deficiency syndromes (1999), 2022, 02-01, Volume: 89, Issue:2

Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Parasitemia; Plasmodium falciparum; Reverse Transcriptase Inhibitors; Ritonavir

2022

Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Aug-01, Volume: 59, Issue:3

Topics: Antimalarials; Artemisinins; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Lopinavir; Malaria; Male; Nevirapine; Parasitemia; Quinolines; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Outcome; Uganda

2014

Other Studies

1 other study(ies) available for lopinavir and Parasitemia

Article	Year
HIV protease inhibitors block parasite signal peptide peptidases and prevent growth of Babesia microti parasites in erythrocytes. Biochemical and biophysical research communications, 2019, 09-10, Volume: 517, Issue:1 Topics: Animals; Aspartic Acid Endopeptidases; Atazanavir Sulfate; Babesia microti; Babesiosis; Erythrocytes; HIV Protease Inhibitors; Humans; Lopinavir; Mice; Parasitemia; Protozoan Proteins	2019

Article

Year

HIV protease inhibitors block parasite signal peptide peptidases and prevent growth of Babesia microti parasites in erythrocytes.

Biochemical and biophysical research communications, 2019, 09-10, Volume: 517, Issue:1

Topics: Animals; Aspartic Acid Endopeptidases; Atazanavir Sulfate; Babesia microti; Babesiosis; Erythrocytes; HIV Protease Inhibitors; Humans; Lopinavir; Mice; Parasitemia; Protozoan Proteins

2019